ALGORHYTHM HOLDINGS INC (RIME) Stock Fundamental Analysis

NASDAQ:RIME • US8293225020

1.84 USD
-0.27 (-12.8%)
At close: Feb 23, 2026
1.81 USD
-0.03 (-1.63%)
Pre-Market: 2/24/2026, 5:02:49 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Overall RIME gets a fundamental rating of 1 out of 10. We evaluated RIME against 60 industry peers in the Household Durables industry. RIME has a bad profitability rating. Also its financial health evaluation is rather negative. RIME is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year RIME has reported negative net income.
  • RIME had a negative operating cash flow in the past year.
  • In multiple years RIME reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: RIME reported negative operating cash flow in multiple years.
RIME Yearly Net Income VS EBIT VS OCF VS FCFRIME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

  • RIME has a worse Return On Assets (-264.67%) than 98.33% of its industry peers.
  • The Return On Equity of RIME (-1935.47%) is worse than 96.67% of its industry peers.
Industry RankSector Rank
ROA -264.67%
ROE -1935.47%
ROIC N/A
ROA(3y)-51.31%
ROA(5y)-31.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RIME Yearly ROA, ROE, ROICRIME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

  • Looking at the Gross Margin, with a value of 18.56%, RIME is doing worse than 78.33% of the companies in the same industry.
  • RIME's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for RIME so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.83%
GM growth 5Y-4.28%
RIME Yearly Profit, Operating, Gross MarginsRIME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • RIME does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for RIME has been reduced compared to 1 year ago.
  • The number of shares outstanding for RIME has been increased compared to 5 years ago.
  • The debt/assets ratio for RIME is higher compared to a year ago.
RIME Yearly Shares OutstandingRIME Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
RIME Yearly Total Debt VS Total AssetsRIME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • Based on the Altman-Z score of -9.06, we must say that RIME is in the distress zone and has some risk of bankruptcy.
  • RIME's Altman-Z score of -9.06 is on the low side compared to the rest of the industry. RIME is outperformed by 93.33% of its industry peers.
  • A Debt/Equity ratio of 2.86 is on the high side and indicates that RIME has dependencies on debt financing.
  • With a Debt to Equity ratio value of 2.86, RIME is not doing good in the industry: 96.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.86
Debt/FCF N/A
Altman-Z -9.06
ROIC/WACCN/A
WACC13.44%
RIME Yearly LT Debt VS Equity VS FCFRIME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

  • A Current Ratio of 0.53 indicates that RIME may have some problems paying its short term obligations.
  • The Current ratio of RIME (0.53) is worse than 98.33% of its industry peers.
  • A Quick Ratio of 0.53 indicates that RIME may have some problems paying its short term obligations.
  • RIME's Quick ratio of 0.53 is on the low side compared to the rest of the industry. RIME is outperformed by 81.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.53
RIME Yearly Current Assets VS Current LiabilitesRIME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 68.34% over the past year.
  • RIME shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -44.67%.
  • The Revenue for RIME have been decreasing by -12.76% on average. This is quite bad
EPS 1Y (TTM)68.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-104.38%
Revenue 1Y (TTM)-44.67%
Revenue growth 3Y-19.95%
Revenue growth 5Y-12.76%
Sales Q2Q%-83.58%

3.2 Future

  • The Earnings Per Share is expected to decrease by -47.61% on average over the next years. This is quite bad
  • Based on estimates for the next years, RIME will show a very strong growth in Revenue. The Revenue will grow by 2301.92% on average per year.
EPS Next YN/A
EPS Next 2Y-47.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-86.17%
Revenue Next 2Y2301.92%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RIME Yearly Revenue VS EstimatesRIME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5B 10B 15B 20B
RIME Yearly EPS VS EstimatesRIME Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2026 0 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • RIME reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RIME Price Earnings VS Forward Price EarningsRIME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RIME Per share dataRIME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80 -100

4.3 Compensation for Growth

  • A cheap valuation may be justified as RIME's earnings are expected to decrease with -47.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-47.61%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for RIME!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALGORHYTHM HOLDINGS INC

NASDAQ:RIME (2/23/2026, 8:13:34 PM)

Premarket: 1.81 -0.03 (-1.63%)

1.84

-0.27 (-12.8%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)11-28
Earnings (Next)04-14
Inst Owners2.21%
Inst Owner Change-28.3%
Ins Owners0.89%
Ins Owner Change0%
Market Cap10.60M
Revenue(TTM)14.46M
Net Income(TTM)-28.70M
Analysts82.86
Price Target5.1 (177.17%)
Short Float %7.4%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.73
P/FCF N/A
P/OCF N/A
P/B 7.15
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-110.55
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.65
FCFYN/A
OCF(TTM)-1.55
OCFYN/A
SpS2.51
BVpS0.26
TBVpS-0.66
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -264.67%
ROE -1935.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.56%
FCFM N/A
ROA(3y)-51.31%
ROA(5y)-31.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.83%
GM growth 5Y-4.28%
F-Score3
Asset Turnover1.33
Health
Industry RankSector Rank
Debt/Equity 2.86
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -874.6%
Cap/Sales 3.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.53
Quick Ratio 0.53
Altman-Z -9.06
F-Score3
WACC13.44%
ROIC/WACCN/A
Cap/Depr(3y)61.29%
Cap/Depr(5y)88.63%
Cap/Sales(3y)0.39%
Cap/Sales(5y)0.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-104.38%
EPS Next YN/A
EPS Next 2Y-47.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-44.67%
Revenue growth 3Y-19.95%
Revenue growth 5Y-12.76%
Sales Q2Q%-83.58%
Revenue Next Year-86.17%
Revenue Next 2Y2301.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-47620%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6068.67%
OCF growth 3YN/A
OCF growth 5YN/A

ALGORHYTHM HOLDINGS INC / RIME FAQ

Can you provide the ChartMill fundamental rating for ALGORHYTHM HOLDINGS INC?

ChartMill assigns a fundamental rating of 1 / 10 to RIME.


What is the valuation status for RIME stock?

ChartMill assigns a valuation rating of 0 / 10 to ALGORHYTHM HOLDINGS INC (RIME). This can be considered as Overvalued.


Can you provide the profitability details for ALGORHYTHM HOLDINGS INC?

ALGORHYTHM HOLDINGS INC (RIME) has a profitability rating of 1 / 10.


What is the financial health of ALGORHYTHM HOLDINGS INC (RIME) stock?

The financial health rating of ALGORHYTHM HOLDINGS INC (RIME) is 0 / 10.